The Office of New Drugs at the FDA is in the middle of a major, phased reorganization at the moment. All divisions are impacted, including Neurology, which will be split in two, and Psychiatry.
As part of the reorganization, starting this month, a new Office of Rare Diseases, Paediatrics, Urological & Reproductive Medicine will be formed. In addition, there will be new divisions created for Pharm/Tox for Neuroscience and Pharm/Tox for Rare Diseases, Paediatrics, Urological & Reproductive Medicine.
https://www.fda.gov/drugs/regulator...nges-office-translational-sciences-and-office
The Office of New Drugs at the FDA is in the middle of a major,...
-
- There are more pages in this discussion • 131 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.65 |
Change
-0.540(2.81%) |
Mkt cap ! $2.383B | |||
| Open | High | Low | Value | Volume |
| $18.98 | $19.15 | $18.50 | $10.51M | 560.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $18.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.65 | 1127 | 2 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |